B
Ballarat Health Services | Ballarat Regional Integrated Cancer Center - Oncology Department
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Tinzaparin
Dalteparin
Anastrozole
Selpercatinib
Nafamostat Mesilate
Exemestane
Imlunestrant
Tamoxifen
Letrozole
LY3537982
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 4 total trials
The main purpose of this study is to measure how well imlunestrant works compared to standard hormone therapy in participants with early breast cance...
Enrolling
Breast Neoplasms
Drug: Anastrozole
Drug: Tamoxifen
The purpose of this study is to assess if adding LY3537982 in combination with standard of care anti-cancer drugs is more effective than standard of...
Enrolling
Carcinoma, Non-Small-Cell Lung
Neoplasm Metastasis
Drug: Carboplatin
Drug: LY3537982
The reason for this study is to see if the study drug, selpercatinib, compared to placebo is effective and safe in delaying cancer return in particip...
Enrolling
Carcinoma, Non-Small-Cell Lung
Drug: Placebo
Drug: Selpercatinib
Trial sponsors
U
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems